Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-09-055445
Filing Date
2009-03-16
Accepted
2009-03-16 16:25:20
Documents
14
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 943122
2 FORM OF RESTRICTED STOCK UNIT AGREEMENT dex1051.htm EX-10.5.1 19399
3 SUMMARY OF DIRECTOR COMPENSATION dex106.htm EX-10.6 5897
4 SUMMARY OF 2009 BONUS TARGETS dex107.htm EX-10.7 3851
5 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 3595
6 CERTIFICATION OF CEO PURSUANT TO SECTION 302 dex311.htm EX-31.1 9732
7 CERTIFICATION OF CFO PURSUANT TO SECTION 302 dex312.htm EX-31.2 9980
8 CERTIFICATION OF CEO PURSUANT TO SECTION 906 dex321.htm EX-32.1 2813
9 CERTIFICATION OF CFO PURSUANT TO SECTION 906 dex322.htm EX-32.2 2749
11 GRAPHIC g45022g39k97.jpg GRAPHIC 56578
12 GRAPHIC g45022g46d85.jpg GRAPHIC 2477
13 GRAPHIC g45022g53n57.jpg GRAPHIC 45292
14 GRAPHIC g45022g70q06.jpg GRAPHIC 8866
15 GRAPHIC g45022g83s91.jpg GRAPHIC 4143
  Complete submission text file 0001193125-09-055445.txt   1164871
Mailing Address
Business Address 4222 EMPEROR BLVD SUITE 350 DURHAM NC 27703 919-941-5206
ICAGEN INC (Filer) CIK: 0000902622 (see all company filings)

EIN.: 561785001 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34217 | Film No.: 09684633
SIC: 2834 Pharmaceutical Preparations